Myriad Genetics Inc.

NASDAQ: MYGN
Share price (3/12/25): $10.41
Market cap (3/12/25): $951 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Automatic shelf registration

Registration of securities for employees

Registration of securities for employees

Ownership Filter

Ancona Margaret

Haas Kevin Richard

News Filter

Reports Fourth Quarter and Full-Year 2024 Financial Results; Full-Year 2024 Revenue of $838 Million Grew 11% Year-Over-Year, the Second Consecutive Year of Double-Digit Revenue Growth

Announces Select Preliminary Fourth Quarter and Full Year 2024 Financial Results and Introduces Full Year 2025 Financial Guidance

Expands Board of Directors With Election of Mark S. Davis as New Board Member

Material Disclosure, Financial Statements or Exhibits

Reports Third Quarter 2024 Financial Results; Updates 2024 Financial Guidance

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Confidential treatment order

Scanned paper annual report submission

Scanned paper annual report submission